This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Dems push tougher rules after Avandia diabetes drug case
Democrats cite safety concerns over Glaxo SmithKline Avandia to attack FDA in Congress. Waxman criticizes delayed warnings and urges stronger industry regulation as hearings unfold and black box labels loom for Avandia and Actos.
MENTIONED IN THIS ARTICLE
Dems
Washington
Food and Drug Administration
Congress
California
Henry Waxman
House Committee On Oversight and Government Reform
FDA
Waxman Waxman
New England Journal of Medicine
Drew von Eschenbach
von Eschenbach
Glaxo
Takeda Pharmaceuticals
Avandia
Actos
Chris Wiehbacher
U.S
Sociated Press
Moncef Slaoul
Glaxo-SmithKline
Capitol Hill
House Oversight and Government Reform Committee